Alphabet-backed start-up Isomorphic Labs has added another name to the roster of pharma companies tapping into its AI-based drug discovery engine. Johnson & Johnson's Janssen Biotech unit is the ...

Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on Tuesday.

Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical ‌trials by the end of 2026, founder and CEO ‌Demis Hassabis said on ...

With last year’s news about “The Martian” screenwriter Drew Goddard taking the helm from Lana and Lily Wachowski for a new “Matrix” film, Laurence Fishburne expressed his hesitancy in reprising his ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. The news comes as tech ...

Add Yahoo as a preferred source to see more of our stories on Google. In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s ...

As Isomorphic Labs aims its artificial intelligence tools at drug development, it’s setting up a new outpost in the biotech hub of Cambridge. Founded in 2021 as a spinoff of Alphabet AI company ...

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...

Set between The Matrix and The Matrix Reloaded, Kid’s Story focuses upon a teenage boy named Michael Karl Popper (voiced in the English dub by Watson) who has long sensed something being off in the ...

We're on our way back to The Matrix. That's the word from Warner Bros Pictures co-chairman/CEOs Mike De Luca and Pam Abdy via Deadline. During a discussion about Warner Bros. reviving IPs, the subject ...